Relationship between recurrent vulvovaginal candidosis and immune mediators in vaginal fluid

被引:36
作者
Weissenbacher, Tobias M. [1 ]
Witkin, Steven S. [3 ]
Gingelmaier, Andrea [1 ]
Scholz, Christoph [1 ]
Friese, Klaus [1 ,2 ]
Mylonas, Ioannis [1 ]
机构
[1] Univ Munich, Dept Obstet & Gynecol 1, D-80337 Munich, Germany
[2] Univ Munich, Dept Obstet & Gynaecol, Klinikum Grosshadern, D-80337 Munich, Germany
[3] Cornell Univ, Dept Obstet & Gynaecol, Weill Med Coll, New York, NY 10021 USA
关键词
Interleukin-4; Interleukin-5; Interleukin; 13; Prostaglandin E-2; Candida-specific IgE; Total-IgE; Th1 immune response; Th2 immune response; Recurrent candidosis; CANDIDIASIS; VAGINITIS; ALBICANS; WOMEN; RISK;
D O I
10.1016/j.ejogrb.2009.01.010
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: Recurring vulvovaginal candidosis (RVVC) is a common vaginal discharge, affecting 75% of all women at least once in their life. In 5% of these women, this infection is recurring. Recent studies have focused on determining the importance of vaginal-associated immunity. To investigate the effects of immune mediators and the probability of an immune defect as well as localized allergic responses due to candida, we examined the cytokines IL-4, IL-5, IL-13 as well as prostaglandin E-2 (PgE(2)), candida-specific IgE and total-IgE in patients with a clinical diagnosis of RVVC. Study design: In 104 symptomatic and 41 asymptomatic patients, regarding clinical symptoms of RVVC. vaginal fluids were measured by ELISA for the immune mediators IL-4, IL-5, IL-13, PgE(2), candida-specific IgE and total-IgE. Polymerase chain reactions as well as culture were used for candida detection. Results: Concerning IL-5, IL-13 and total-IgE no statistically significant difference was found. Those women with a history of RVVC and who were currently symptomatic had elevated concentrations of IL-4 (p < .0001), PgE(2) (p < .0001) and candida-specific IgE (p < 0.02) in their vaginal fluids compared to women with no clinical symptoms. Those three interleukins showed no significant differences between symptomatic patients who were positive or negative for Candida albicans or Candida glabrata. Conclusion: These findings indicate that women with clinical vaginal symptoms have a localized vaginal immunosuppression which might be the cause of their symptoms. Greatly elevated vaginal PgE2 levels can be a consequence of a localized allergic response. An allergic reaction to candida components may be the cause of the allergic response in those women with high levels of candida-specific IgE. In women with elevated PgE(2), treatment with an antihistamine or prostaglandin synthesis inhibitor might be beneficial. (C) 2009 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:59 / 63
页数:5
相关论文
共 20 条
[1]   Evidence of a TH1-shift of local vaginal inflammatory response during bacterial vaginosis [J].
Anton, G. ;
Rid, J. ;
Mylonas, I. ;
Friese, K. ;
Weissenbacher, E. -R. .
INFECTION, 2008, 36 (02) :147-152
[2]   Growth inhibition of Candida albicans by human vaginal epithelial cells [J].
Barousse, MM ;
Steele, C ;
Dunlap, K ;
Espinosa, T ;
Boikov, D ;
Sobel, JD ;
Fidel, PL .
JOURNAL OF INFECTIOUS DISEASES, 2001, 184 (11) :1489-1493
[3]   Do allergens induce type-2 immune responses? [J].
Comoy, E ;
Pestel, J ;
Stewart, GA ;
Finkelman, F ;
Capron, A ;
Thyphronitis, G .
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1999, 118 (2-4) :399-402
[4]  
Dan M, 2003, ISRAEL MED ASSOC J, V5, P629
[5]   Vaginal colonization by Candida in asymptomatic women with and without a history of recurrent vulvovaginal candidiasis [J].
Giraldo, P ;
von Nowaskonski, A ;
Gomes, FAM ;
Linhares, I ;
Neves, NA ;
Witkin, SS .
OBSTETRICS AND GYNECOLOGY, 2000, 95 (03) :413-416
[6]   Effects of interleukin-13 on antifungal activity of human monocytes against Candida albicans [J].
Katsifa, H ;
Tsaparidou, S ;
Diza, E ;
Gil-Lamaignere, C ;
Walsh, TJ ;
Roilides, E .
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, 2001, 31 (03) :211-217
[7]   Increased levels of Candida albicans mannan-specific T-cell-derived antigen binding molecules in patients with invasive candidiasis [J].
Kosonen, J ;
Rantala, A ;
Little, CH ;
Lintu, P ;
Harjamäki, PR ;
Georgiou, GM ;
Cone, RE ;
Savolainen, J .
CLINICAL AND VACCINE IMMUNOLOGY, 2006, 13 (04) :467-474
[8]  
Linhares L M, 2001, Infect Dis Obstet Gynecol, V9, P221
[9]   FUNGAL VULVO-VAGINITIS [J].
MACCATO, ML ;
KAUFMAN, RH .
CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 1991, 3 (06) :849-852
[10]   Facts and myths on recurrent vulvovaginal candidosis -: a review on epidemiology, clinical manifestations, diagnosis, pathogenesis and therapy [J].
Mårdh, PA ;
Rodrigues, AG ;
Genç, M ;
Novikova, N ;
Martinez-de-Oliveira, J ;
Guaschino, S .
INTERNATIONAL JOURNAL OF STD & AIDS, 2002, 13 (08) :522-539